Anti-SPATA12 monoclonal antibody

Pre-made anti-SPATA12 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SPATA12/SPATA12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2748-Ab-1/ GM-Tg-hg-IP2748-Ab-2Anti-Human SPATA12 monoclonal antibodyHuman
GM-Tg-rg-IP2748-Ab-1/ GM-Tg-rg-IP2748-Ab-2Anti-Rat SPATA12 monoclonal antibodyRat
GM-Tg-mg-IP2748-Ab-1/ GM-Tg-mg-IP2748-Ab-2Anti-Mouse SPATA12 monoclonal antibodyMouse
GM-Tg-cynog-IP2748-Ab-1/ GM-Tg-cynog-IP2748-Ab-2Anti-Cynomolgus/ Rhesus macaque SPATA12 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2748-Ab-1/ GM-Tg-felg-IP2748-Ab-2Anti-Feline SPATA12 monoclonal antibodyFeline
GM-Tg-cang-IP2748-Ab-1/ GM-Tg-cang-IP2748-Ab-2Anti-Canine SPATA12 monoclonal antibodyCanine
GM-Tg-bovg-IP2748-Ab-1/ GM-Tg-bovg-IP2748-Ab-2Anti-Bovine SPATA12 monoclonal antibodyBovine
GM-Tg-equg-IP2748-Ab-1/ GM-Tg-equg-IP2748-Ab-2Anti-Equine SPATA12 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2748-Ab-1/ GM-Tg-hg-IP2748-Ab-2; GM-Tg-rg-IP2748-Ab-1/ GM-Tg-rg-IP2748-Ab-2;
GM-Tg-mg-IP2748-Ab-1/ GM-Tg-mg-IP2748-Ab-2; GM-Tg-cynog-IP2748-Ab-1/ GM-Tg-cynog-IP2748-Ab-2;
GM-Tg-felg-IP2748-Ab-1/ GM-Tg-felg-IP2748-Ab-2; GM-Tg-cang-IP2748-Ab-1/ GM-Tg-cang-IP2748-Ab-2;
GM-Tg-bovg-IP2748-Ab-1/ GM-Tg-bovg-IP2748-Ab-2; GM-Tg-equg-IP2748-Ab-1/ GM-Tg-equg-IP2748-Ab-2
Products NameAnti-SPATA12 monoclonal antibody
Formatmab
Target NameSPATA12
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SPATA12 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2748-Ag-1Recombinant multi-species SPT12/ SPATA12/ SRG5 protein


    Target information

    Target IDGM-IP2748
    Target NameSPATA12
    Gene ID353324,704982,102901846
    Gene Symbol and SynonymsSPATA12,SRG5
    Uniprot AccessionQ7Z6I5
    Uniprot Entry NameSPT12_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000186451
    Target ClassificationN/A

    The target: SPATA12, gene name: SPATA12, also named as SRG5. This gene is expressed primarily in testis and may play a role in testicular development and spermatogenesis. The encoded protein may be upregulated in response to ultraviolet-C radiation. [provided by RefSeq, Dec 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.